ANZALONE CHRISTOPHER RICHARD (Chief Executive Officer) sold 0.7% of their position (26.03K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.77M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 12/23/2025ACC: 0001423029-25-000007
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-26.03K
Net shares
Net seller
$1.77M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
26.03K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−3.98K
Price / share
$66.67
Trade value
$265.28K
% of position
0.1%
12/19/2025
3.83M→3.83M
Common Stock
Direct
Shares
−8.15K
Price / share
$68.01
Trade value
$554.08K
% of position
0.2%
12/19/2025
3.83M→3.82M
Common Stock
Direct
Shares
−1.32K
Price / share
$68.48
Trade value
$90.33K
% of position
0.0%
12/19/2025
3.82M→3.82M
Common Stock
Direct
Shares
−10.01K
Price / share
$68.33
Trade value
$684.12K
% of position
0.3%
12/22/2025
3.82M→3.81M
Common Stock
Direct
Shares
−2.57K
Price / share
$68.85
Trade value
$177.22K
% of position
0.1%
12/22/2025
3.81M→3.81M
Total
Net shares
−26.03K
Net value
-$1.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −3.98K | $66.67 | $265.28K | 0.1% | 3.83M | 3.83M |
| Common Stock Direct | 12/19/2025 | S · Sale | −8.15K | $68.01 | $554.08K | 0.2% | 3.83M | 3.82M |
| Common Stock Direct | 12/19/2025 | S · Sale | −1.32K | $68.48 | $90.33K | 0.0% | 3.82M | 3.82M |
| Common Stock Direct | 12/22/2025 | S · Sale | −10.01K | $68.33 | $684.12K | 0.3% | 3.82M | 3.81M |
| Common Stock Direct | 12/22/2025 | S · Sale | −2.57K | $68.85 | $177.22K | 0.1% | 3.81M | 3.81M |
| Total | −26.03K | -$1.77M | ||||||
Derivative Transactions0
No derivative transactions reported